Euro-Med Laboratories Phil., Inc.
Euro-Med Laboratories Phil., Inc., commonly referred to as Euro-Med, is a leading player in the pharmaceutical and healthcare industry, headquartered in the Philippines. Established in 1992, the company has made significant strides in providing high-quality medical products and services across the Asia-Pacific region.
Specialising in the distribution of pharmaceuticals, medical devices, and diagnostic products, Euro-Med is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of healthcare solutions that cater to the evolving needs of healthcare professionals and patients alike.
With a strong market presence, Euro-Med has achieved notable milestones, including partnerships with renowned global manufacturers. This positions the company as a trusted provider in the healthcare sector, dedicated to enhancing patient care through reliable and effective medical solutions.
-21 vs industry average
Euro-Med Laboratories Phil., Inc.’s score of 17 is lower than 13% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Euro-Med Laboratories Phil., Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
Euro-Med Laboratories Phil., Inc.'s reported carbon emissions
In 2023, Euro-Med Laboratories Phil., Inc. reported total emissions of approximately 20,620,210 kg CO2e, comprising 7,803,600 kg CO2e from Scope 1 and 12,578,610 kg CO2e from Scope 2 emissions. This data reflects a commitment to transparency in their carbon footprint, although no Scope 3 emissions data was disclosed. Comparatively, in 2022, the company recorded total emissions of approximately 19,763,000 kg CO2e, with Scope 1 emissions at 7,932,000 kg CO2e and Scope 2 emissions at 11,643,000 kg CO2e. This indicates a slight increase in emissions from 2022 to 2023. Euro-Med Laboratories Phil., Inc. has not set specific reduction targets or initiatives as part of their climate commitments, nor do they participate in recognised frameworks such as the Science Based Targets initiative (SBTi). The absence of defined reduction strategies suggests a need for further development in their climate action plans. As a current subsidiary of Euro-Med Laboratories Phil., Inc., the emissions data is cascaded from the parent organisation, ensuring consistency in reporting practices. The company continues to focus on improving its sustainability efforts in alignment with industry standards.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Euro-Med Laboratories Phil., Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Euro-Med Laboratories Phil., Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Euro-Med Laboratories Phil., Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project